RT @pashtoonkasi
🆕Published today🗞️
@ASCO #ASCODailyNews

“Utility & Debate of #LiquidBiopsies in Surveillance Setting”

The❓of what go do if someone is #ctDNA➕. My 2 cents👇🏾.

💡Adjuvant-Plus or #MRD-plus setting➡️🆕platform for trials.

@OncoAlert @DrawImpacts

Link: https://dailynews.ascopubs.org/do/utility-and-debate-liquid-biopsy-assays-surveillance-setting#.ZAkizbGuXdg.twitter

Post doctoral fellow @hopkinskimmel

https://jobrxiv.org/job/johns-hopkins-school-of-medicine-27778-post-doctoral-fellow/?feed_id=36652

#ScienceJobs #job @ValsamoA #genomics #liquidbiopsies #cancer #immunotherapy
Baltimore #UnitedStatesUS #PostdoctoralFellow
https://jobrxiv.org/job/johns-hopkins-school-of-medicine-27778-post-doctoral-fellow/?feed_id=36652

RT @pashtoonkasi
👇🏾A lot of great data & discussion here on this🧵by @MPishvaian @TumorBoardTues. #GI23 @ASCO

Additionally, intriguing insights with practical implications on🩸#ctDNA #LiquidBiopsies: data on kinetics 📉, post-op cfDNA🆚ctDNA interactions/timing, & data in anal cancer. @OncoAlert https://twitter.com/mpishvaian/status/1620588991828590592

RT @pashtoonkasi
👇🏾A lot of great data & discussion here on this🧵by @MPishvaian @TumorBoardTues. #GI23 @ASCO

Additionally, intriguing insights with practical implications on🩸#ctDNA #LiquidBiopsies: data on kinetics 📉, post-op cfDNA🆚ctDNA interactions/timing, & data in anal cancer. @OncoAlert https://twitter.com/mpishvaian/status/1620588991828590592

Post doctoral fellow @hopkinskimmel

https://jobrxiv.org/job/johns-hopkins-school-of-medicine-27778-post-doctoral-fellow/?feed_id=34956

#ScienceJobs #job @ValsamoA #genomics #liquidbiopsies #cancer #immunotherapy
Baltimore #UnitedStatesUS #PostdoctoralFellow
https://jobrxiv.org/job/johns-hopkins-school-of-medicine-27778-post-doctoral-fellow/?feed_id=34956

RT @science_seattle@twitter.com

A suite of new computational tools 🛠️, developed at @FredHutch@twitter.com by Dr. Gavin Ha (@GavinHa@twitter.com), could help scientists use #LiquidBiopsies to get more information about #tumor gene regulation. 🧬

Learn more: https://bit.ly/3QKTFaL

🐦🔗: https://twitter.com/science_seattle/status/1615387244503638016

RT @pashtoonkasi: 🆕 Just published @NatureMedicine @Nature

Editorial on✍🏽
#LiquidBiopsies & the Tumor Mutational Burden cutoff conundrum.

🩸Blood-TMB or plasma-TMB cutoffs need to be harmonized; across platforms, & tissue🆚 liquid.

💡Thoughts?

#ESMO22
https://t.co/kCNQXsWvmy https://t.co/7PSeRahcjK

@oncology

RT @oncNGS: 📢 The oncNGS #CallForTenders is open!
We look for disruptive solution for predictive, prognostic and diagnostic analysis in 🩸#liquidbiopsies of solid tumours based on🧬#NGS technology.
You can send your offer until the 17th of October!
👉 https://oncngs.eu/index.php/2022/07/18/the-oncngs-call-for-tenders-is-open-2/

🐦🔗: https://nitter.eu/EU_HaDEA/status/1557005453195870209